Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Fuji, Shigeo  [Clear All Filters]
2022
Onishi A, Fuji S, Kitano S, Maeshima AMiyagi, Tajima K, Yamaguchi J, Kawashima I, Kawajiri A, Takemura T, Ito A, et al. Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia-lymphoma. Ann Hematol. 2022.
2021
Kurosawa S, Yamaguchi T, Mori A, Tsukagoshi M, Okuda I, Ikeda M, Ueno T, Saito Y, Aihara Y, Matsuba Y, et al. Feasibility and usefulness of recommended screenings at long-term follow-up clinics for hematopoietic cell transplant survivors. Support Care Cancer. 2021.
Fuji S, Byrne M, Nagler A, Mohty M, Savani BN. How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2021.
Kurosawa S, Yamaguchi T, Mori A, Tsukagoshi M, Okuda I, Kayama M, Fuji S, Yamashita T, Ogawa C, Ito A, et al. Prognostic impact of pre-transplant quality of life and its post-transplant longitudinal change after allogeneic hematopoietic cell transplantation: a prospective study that administered SF-12 and EQ-5D. Transplant Cell Ther. 2021.
2020
Fuji S, Kida S, Morishima T, Nakata K, Miyashiro I, Ishikawa J. Clinical outcomes of patients with adult T-cell leukemia-lymphoma in a non-endemic metropolitan area: a retrospective analysis of the population-based Osaka Cancer Registry. Biol Blood Marrow Transplant. 2020.
Harada K, Fuji S, Seo S, Uchida N, Kawakita T, Yano S, Ozawa Y, Yoshioka S, Onishi Y, Noguchi Y, et al. Comparison of immunosuppressant regimens in salvage cord blood transplantation for graft failure after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020.
Watanabe M, Kanda J, Kojima H, Ikeda N, Fuji S, Kanda Y, Saji H, Tanaka H. Wide availability of HLA-matched or a few loci-mismatched donors in the graft-vs-host direction among non-sibling first-degree relatives. HLA. 2020.
2019
Yuda S, Fuji S, Onishi A, Tanaka T, Inamoto Y, Kurosawa S, Kim S-W, Fukuda T. Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2019.
Shinohara A, Oshima K, Fuji S, Umeda K, Kako S, Kurokawa M, Tsukada N, Kasai M, Kondo T, Hashii Y, et al. Hematopoietic stem cell transplantation in solid organ recipients with emphasis on transplant complications: a nationwide retrospective survey on behalf of the JSHCT, transplant complications working group. Biol Blood Marrow Transplant. 2019.
Yoshimitsu M, Fuji S, Utsunomiya A, Nakano N, Ito A, Ito Y, Miyamoto T, Suehiro Y, Kawakita T, Moriuchi Y, et al. Outcomes of allogeneic hematopoietic stem cell transplantation for ATL with HTLV-1 antibody positive donors: Allo-HCT for ATL from HTLV-1 antibody positive donors. Biol Blood Marrow Transplant. 2019.
Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JCarlos, Ratner L, Horwitz S, Fields P, Tanase A, Bumbea H, et al. Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report. J Clin Oncol. 2019:JCO1800501.
Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, et al. Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT. Int J Hematol. 2019.
2018
Ito R, Inamoto Y, Inoue Y, Ito A, Tanaka T, Fuji S, Okinaka K, Kurosawa S, Kim S-W, Yamashita T, et al. Characterization of late acute and chronic graft-versus-host disease according to the 2014 NIH consensus criteria in Japanese patients. Biol Blood Marrow Transplant. 2018.
2016
Tanaka T, Inamoto Y, Yamashita T, Fuji S, Okinaka K, Kurosawa S, Kim S-W, Tanosaki R, Fukuda T. Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016.
2015
Hashimoto H, Kitano S, Ueda R, Ito A, Tada K, Fuji S, Kim S-W, Yamashita T, Tomura D, Nukaya I, et al. Erratum to: Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2015.
Fuji S, Einsele H, Savani BN, Kapp M. Systematic nutritional support in allogeneic HSCT recipients. Biol Blood Marrow Transplant. 2015.
2014
Kanda J, Ichinohe T, Fuji S, Maeda Y, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T, Nakamae H, et al. The impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: A retrospective analysis from the JSHCT. Biol Blood Marrow Transplant. 2014.
Fuji S, Kapp M, Einsele H. Possible Implication of Bacterial Infection in Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Front Oncol. 2014;4:89.
2013
Fuji S, Kapp M, Einsele H. Alloreactivity of Virus-Specific T Cells: Possible Implication of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effects. Front Immunol. 2013;4:330.
Fuji S, Ueno N, Hiramoto N, Asakura Y, Yakushijin K, Kamiyama Y, Kurosawa S, Kim S-W, Heike Y, Yamashita T, et al. Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases. Int J Hematol. 2013.